News

  • H
    Healthcare
  • L
    LifeSciences
  • S
    Stability & Bio Storage
  • C
    Corporate

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Henderson Global Investors which now stands at 60,142,788 shares, representing 19.18% of the Company’s ordinary share capital.

Preliminary results for the year ended 31 December 2014

Source BioScience plc today announces its unaudited preliminary results for the year ended 31 December 2014.

State of the Art Humidity Generation Technology at our Stability and Bio Storage Facilities

Source BioScience has been providing outsourced controlled environment equipment and storage to the pharmaceutical industry, for forty years.

Source BioScience opened doors for Company Presentation Day

Source BioScience Opened Doors for Company Presentation Day

Notice of Results

Source BioScience plc will be announcing its preliminary results for the year ended 31 December 2014 on Wednesday 25th March 2015.

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Henderson Global Investors which now stands at 58,066,631 shares, representing 18.51% of the Company's issued share capital.

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Oryx International Growth Fund Limited which now stands at 41,767,620 shares, representing 13.32% of the issued ordinary share capital.